Market Place
Sourcing Support
Centessa Pharma To No Longer Develop Lixivaptan For Treatment Of ADPKD
03 Jun 2022 //
NASDAQ
Palladio Biosciences Announces First Patient Dosed The ALERT Study
17 Nov 2020 //
BIOSPACE
Palladio Announces First Patient Dosed With Lixivaptan in The ALERT Study
17 Nov 2020 //
BUSINESSWIRE
Palladio Biosciences Announces Presentation of Data from a Study of Lixivaptan
20 Oct 2020 //
BUSINESSWIRE
Palladio Completes $20 Million Series B Financing
25 Sep 2020 //
BUSINESSWIRE
Palladio`s Announces Presentations of ELiSA Ph 2 Study Results & Ph3 Lixivaptan
05 Nov 2019 //
BUSINESSWIRE
Palladio Biosciences Announces ELiSA Ph 2 Study Results and Phase 3 Lixivaptan
05 Nov 2019 //
BUSINESSWIRE
Palladio Biosciences Announces Dosing of First Patients with Lixivaptan
18 Dec 2018 //
BUSINESSWIRE
Palladio Biosciences Receives Orphan Drug from the U.S. FDA for Lixivaptan
05 Oct 2017 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.